In a move hospital officials are calling a game-changer, Hackensack Meridian Mountainside Medical Center is integrating the Cathworks FFRangio System into its Cardiac Catheterization Laboratory.
HMH Mountainside CEO Tim O’Brien said this cutting-edge, noninvasive tool enhances decision-making during coronary interventions — and that this advanced technology reaffirms the lab’s commitment to providing world-class care to patients with coronary artery disease.
“The introduction of Cathworks at Mountainside Medical Center underscores our dedication to adopting the most advanced technologies available to enhance patient care,” he said. “We are thrilled to offer our patients a less-invasive and more accurate approach to coronary artery disease diagnosis and treatment.
“This innovation is a game-changer for our community.”
The integration of Cathworks technology at Mountainside Medical Center’s Cardiac Catheterization Laboratory marks a new era in coronary care. By leveraging this innovative system, the lab is poised to continue leading the way in delivering top-tier cardiac care to the community, HMH Mountainside officials said.
Dr. Ankitkumar Patel, the Cardiac Catheterization Laboratory director, said the impact will be great.
“Cathworks represents a significant leap forward in how we approach coronary interventions,” he said. “The ability to assess fractional flow reserve (FFR) non-invasively in real time allows us to make better-informed decisions that directly impact patient outcomes. It’s an exciting development for our lab and for the future of cardiology.”
Dr. Sarina Sachdev agreed.
“As an interventional cardiologist, my priority is always to ensure the best possible outcomes for my patients,” she said. “With Cathworks, we can provide a more accurate diagnosis and tailor our treatments with greater precision, all while reducing the need for invasive procedures.
“This is a major advancement in the field, and I’m excited to see the positive impact it will have on our patients.”
